India is one of the largest exporters of pharmaceuticals and generic medicines in the world. The Indian Pharmaceutical sector has witnessed steady growth over the years and is a significant contributor to the country’s economy. For this growth to continue into the coming years, affordable and
reliable power is required for the Pharmaceutical Industry as power tariffs increase every year, substantially impacting manufacturing costs. Many pharmaceutical companies are committed to the cause of sustainability, not just in business terms, but also in the environmental sense by adopting innovative technologies to reduce energy consumption and imbibing resource management practices in their manufacturing processes.
Pharmaceutical Industry requires a massive amount of power for operating. One such large pharmaceutical company decided to tackle the problem of increasing power tariffs by adopting a rooftop solar power plant. U-Solar’s attractive OPEX offering made economic sense to this fast-growing company, wherein they did not have to invest in the construction of the solar power plant and are now enjoying the benefits of sourcing solar energy. The company has signed a long-term PPA with a 3rd party power producer for procuring power at a rate that is 20-30% lower than the retail electricity price offered by the state DISCOM.
The 956 kWp solar PV system that has been installed is a combination of ground-mount and rooftop configuration. While 916 kWp solar PV system was set up on the ground using 2820 nos. of high-performance 325 Wp RenewSys poly-crystalline solar PV modules, 8 nos. of 92 kW KACO string inverters. Likewise, a 40 kWp PV system was installed on the rooftop using 120 nos. of high-performance 330 Wp RenewSys poly-crystalline solar PV modules, 1 no. 22 kW Sungrow inverter. For data monitoring and communication, WebdynSun Data Logger & Monitoring System has been configured at the site to aid the operation and maintenance of the solar power plant. The plant was commissioned in the month of June 2019 and built on a single-axis seasonal tracking system that improves the generation by 8-10%.
The Pharmaceutical Industry in India is expected to grow to $55 bn. by 2020. Considering the rising energy demands of the industry in tandem with escalating retail power prices, the time is right for pharmaceutical companies to adopt solar energy. The uptake of power from renewable sources like solar can happen at zero capital investment by partnering with U-Solar and having a solar power plant installed in your manufacturing/warehousing premises, without the hassle of building, operating, and maintaining the same.
If your organization is looking to adopt solar, please feel free to get in touch with us. We believe in partnering with our clients on their sustainability journey.
Email us at info@usolar.in
WhatsApp us at +916366226970 | https://wa.me/916366236970